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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S27025.6%, 55.3%), and 55.6% for L5S1 (95% CI¼ 43.3%, 67.2%); two level FJAwas
not observed. The prevalence was signiﬁcantly greater at the L5S1 level for
symptomatic FJA than asymptomatic FJOA (p<0.01); the rates were not
signiﬁcantly different at level L45 (p¼0.49). Comparisons were not per-
formed at other levels since FJA/FJOA was not observed in both groups.
Conclusion: CLBP due to FJA most commonly occurs at L5S1. Morphologic
abnormalities indicative of FJOA in asymptomatic adults occur most
commonly at L45. These ﬁndings suggest that arthritic changes alone are
not the sole etiologic factor mitigating FJA related CLBP.
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LAMIN A DEREGULATION IN HUMAN MESENCHYMAL STEM CELLS
PROMOTES AN IMPAIRMENT IN THEIR CHONDROGENIC POTENTIAL
AND IMBALANCE IN THEIR RESPONSE TO OXIDATIVE STRESS
J. Mateos 1, A. De la Fuente 2, I.A. Lesende-Rodríguez 2, M. Arufe 2,3,
F.J. Blanco 1,3. 1Rheumatology Div., Proteomics Unit-ProteoRed/ISCIII INIBIC-
CHUAC, A Coruña, Spain; 2Dept. of Med., Area of Anatomy and Human
Embryology, University of A Coruña, Spain; 3Rheumatology Div., Cellular
Therapy Unit, CIBER-BBN/ISCIII, INIBIC-CHUAC, A Coruña, Spain
Purpose: Previous work by our group and others indicated that an accumu-
lation of lamin A (LMNA) was associated with the osteoarthritis (OA) chon-
drocyte phenotype. Mutations of this protein are linked to laminopathies and
speciﬁcally to Hutchinson-Guilford Progeria Syndrome (HGPS), an accelerated
agingdisease. Someauthorshaveproposed that aderegulationof LMNAaffects
the differentiation potential of stem cells. In the present study, we examined
the effect of the over-expression of LMNA, or itsmutant formprogerin (PG), on
the mesoderm differentiation potential of MSCs.
Methods:Mesenchymal stem cells (MSCs) from human umbilical cord (UC)
stroma have previously been isolated, expanded and differentiated towards
mesoderm cell lineages. For efﬁcient gene delivery of wt LMNA, PG and GFP
(Green Fluorescence Protein), we used a lentiviral expression system. GFP-
transducedMSCswereusedas control for thedifferentiation study since they
present a differentiation capacity similar to that of untransduced MSCs.
Osteogenic potential was studied by with alizarin red staining to assess
calcium deposits as well as Real-Time PCR of ALP, OC and Runx2 to assess
early and late osteogenic differentiation. Adipogenic potential was studied
with Oil Red staining for lipid droplets and Real-Time PCR of LPL, FABP and
ADIPOQ, for early and late adipogenic differentiation. Chondrogenesis and
hypertrophywere studied using immunohistochemestry and Real-Time PCR
of Aggrecan, MMP-13, Type II Collagen, Type I Collagen and Type I Collagen.
Results: We found that over-expression of LMNA or PG by lentiviral gene
delivery leads to defects in differentiation potential. PG-transduced MSCs
present defects in adipogenic and osteogenic potential, The chondrogenic
potential is defective in PG-MSCs, which present a decrease in COL2 and
Aggrecan as revealed by both immunohistochemystry and Real-Time PCR.
LMNA and PG-transduced MSCs have an increase in hypertrophy markers
(MMP-13 and Type X Collagen) during chondrogenic differentiation, as
well as a decrease in manganese superoxide dismutase (MnSODM) and an
increase of mitochondrial MnSODM-dependent reactive oxygen species
(ROS). ROS synthesis was partially (51%) and totally reverted by N-Acetyl
Cystein, ROS scavenger, (NAC) at 20 and 40 mg/mL respectively for 1 hour in
culture. In addition, defects in chondrogenesis detected by immunohis-
tochemestry and Real Time-PCR are partially reversed by incubations with
NAC at 40 mg/mL for 1 hour.
Conclusions: Our results suggest that OA process could be enhanced by
defects in stem cell differentiation, partially due to imbalance in oxidative
stress.
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SYNGENEIC, MINOR MISMATCHED, AND MAJOR MISMATCHED
TRANSPLANTATION OF MESENCHNMAL STEM CELLS DERIVED FROM
SYNOVIUM IN A RAT MASSIVE MENISCAL DEFECT MODEL
M. Okuno 1,2, I. Sekiya 3, S. Yoshiya 2, T. Muneta 1. 1Orthopaedic Surgery,
Tokyo Med. ana Dental Univ., Tokyo, Japan; 2Orthopaedic Surgery, Hyogo
Coll. of Med., Hyogo, Japan; 3Cartilage Regeneration, Tokyo Med. ana
Dental Univ., Tokyo, JapanPurpose: We previously reported that intraarticular injection of mesen-
chymal stem cells (MSCs) derived from synovium promoted meniscal
regeneration in a rat massive meniscal defect model
Great number of reports described that bone marrow MSCs had immu-
noprivileged effects as well as immunosuppressive effects and that allo-
geneic transplantation of bone marrow MSCs enhanced regeneration in
injury models. However, this is still controversial, and the opposite results
were also reported. As far as synovial MSCs, the inﬂuence of allogeneic
transplantation have not been investigated at all.
In this study, we performed syngeneic transplantation and allogeneic
transplantation of synovial MSCs into the knee joints whose medial
menisci were removed. The area of regenerated menisci were compared
among the allogeneic transplantation groups, the major antigen mismatch
group and the minor antigen mismatch group.
Methods: Cell isolation and culture. This study was approved by institu-
tional animal use committee. Synoviumwas harvested from the knee joint
of 3 strains, F344, Lewis, and ACI rats. After collagenase digestion, nucle-
ated cells derived from synoviumwere expanded and colony forming cells
were collected for transplantation.
Meniscectomy: As recipients, only F344 rats at 10-12 weeks of age were
used. Under anesthesia, a straight incisionwasmade on the anterior side of
the right knee, the anteromedial side of the joint capsule was cut, and the
anterior horn of the medial meniscus was dislocated anteriorly with
a forceps. The meniscus was then cut vertically at the level of medial
collateral ligament, and anterior half of medial meniscus was removed.
Transplantation: Immediately after the skin incision was closed, 5x106
synovial MSCs in 50 ml PBS were injected into the right knee joint of F344
rats. Transplantation of synovial MSCs derived from F344 rat is a syngeneic
model. Transplantation of synovial MSCs derived from Lewis rat is a minor
antigen mismatch model, in which histocompatibility antigens differ partly.
Transplantation of synovial MSCs derived from ACI rat is a major antigen
mismatch model, in which histocompatibility antigens differ greatly.
Macroscopic and microscopic features for menisci were examined, and
regenerative area ofmenisci wasmeasured 4weeks after the surgery. (n¼6).
Results :In the case of synovial MSCs derived from F344 and Lewis rat were
transplanted, into the knee of F344 rat, the regenerative areawas signiﬁcantly
larger in the transplantation side than in the contrateral side (n¼6; p¼0.034).
Contrarily, in the case of synovialMSCsderived fromACI ratwere transplanted,
into thekneeof F344 rat, therewasno signiﬁcantdifferenceof the regenerative
area between in the transplantation side and in the contralateral side. The
regenerative area of medial meniscus in the ACI transplantation group was
signiﬁcantly smaller than in the F344 and ACI groups (n¼6; p<0.03).
Conclusion: For regeneration of removed meniscus, similar results were
obtained between the syngeneic transplantation and the minor mismatch
transplantation model. In the major mismatch model, the results were
inferior to the other models.
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CHONDROGENIC DIFFERENTIATION POTENTIAL OF CD56+ SATELLITE
CELL AND PDGFRa+ MESENCHYMAL STEM CELL DERIVED FROM
HUMAN SKELETAL MUSCLE
T. Oishi 1, A. Uezumi 2, A. Kanaji 1, K. Tsuchida 2, H. Yamada 1. 1Dept. of
Orthopaedics, Fujita Hlth.Univ., Sch. of Med., Toyoake-city, Aichi, Japan;
2Div. for Therapies against Intractable Disease, Inst. for Comprehensive
Med. Sci., Fujita Hlth.Univ., Toyoake-city, Aichi, Japan
Purpose: We recently identiﬁed that murine-derived platelet derived
growth factor-a positive mesenchymal stem cells (PDGFRa+ cells) have the
capacity for adipogenic and osteogenic differentiation in vitro and vivo
(Nature Cell, 2010). We also previously reported that two distinct stem cells,
CD56+ satellite cells and PDGFRa+ cells were identiﬁed in human skeletal
muscle and the human PDGFRa+ cells showed successful engraftment and
bone-like tissue formation in vivo. However, chondrogenic differentiation
potential of human skeletal muscle-derived stem cell is still unknown. The
purpose of this study is that the CD56+ satellite cells and PDGFRa+
mesenchymal stem cells derived from human skeletal muscle are evaluated
for their capacity for chondrogenic differentiation in vitro.
Methods:In this study, we used the human muscular tissue of patients
with osteoarthritis of hip, after informed consent were obtained at the
time of hip surgery. After enzymatic digestion of human skeletal muscle,
Table 1
Groups of study.
Group Cells Scaffolds Culture Medium
I hBM-MSCs Col I Chondrogenic+100 nM PTHrP
II hBM-MSCs Col I + 1% HS Chondrogenic+100 nM PTHrP
III hBM-MSCs Col I + 2% HS Chondrogenic+100 nM PTHrP
IV hBM-MSCs Col I + 3% HS Chondrogenic+100 nM PTHrP
V hBM-MSCs Col I DMEM + 20% FBS+100 nM PTHrP
VI hBM-MSCs Col I + 1% HS DMEM + 20% FBS+100 nM PTHrP
VII hBM-MSCs Col I + 2% HS DMEM + 20% FBS+100 nM PTHrP
VIII hBM-MSCs Col I + 3% HS DMEM + 20% FBS+100 nM PTHrP
IX Chondrocytes Col I DMEM + 10% FBS+100 nM PTHrP
X Chondrocytes Col I + 1% HS DMEM + 10% FBS+100 nM PTHrP
XI Chondrocytes Col I + 2% HS DMEM + 10% FBS+100 nM PTHrP
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S271CD56+ cells and PDGFRa+ cells were isolated by using ﬂow cytometry and
the cells at fourth passage with 80% conﬂuence were collected and re-
suspended in a 15ml polypropylene tube containing 0.5 ml the chondro-
genic differentiation medium at a density of 5x105/ml, centrifuged at
200xg for 5min into cell mass. The cell mass were cultured at 37C in
a humidiﬁed atmosphere containing 5% carbon dioxide for 21 days with
the medium changes twice a week. After the morphological analysis of the
cell mass were performed for 21 day, the cell mass was ﬁxed with 4%
paraformaldehyde at room temperature, frozen and sectioned (6mm-
thick). The section was stained with toluidine blue.
Results: Cartilage-like tissue was not morphologically obtained by the cell
culturewith CD56+ cells, while successful formation of cartilage-like tissue
was achieved by the cell culture with PDGFRa+ cells. Moreover, patho-
logical examination demonstrated that toluidine blue was positive at the
marginal area of the section with PDGFRa+ cells, while toluidine blue-
positive cells of the pathological section with CD56+ cells were not
apparently observed in the section with PDGFRa+ cells.
Conclusions: PDGFRa+ cells seem to be suitable for cartilage formation in
vitro; however, it seems that CD56+ cells cannot adapt to chondrogenic
environment in vitro. In future, we would like to pursue analysis of in vivo
chondrogenic differentiation of PDGFRa+ cells in detail.
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FUNCTIONALLY DISTINCT MESENCHYMAL STEM CELL SUBSETS FROM
THE HUMAN SYNOVIUM
F. Gullo, Jr., C. De Bari, Sr.. Univ. of aberdeen, Aberdeen, United Kingdom;
Francesca Gullo and Cosimo De Bari Regenerative Medicine Group,
Musculoskeletal Research Programme Institute of Medical Sciences,
University of Aberdeen, Aberdeen, UK
Introduction: Osteoarthritis is the commonest joint condition character-
ized by a progressive breakdown of articular cartilage and other joint
tissues. Regenerative medicine offers the opportunity to promote joint
repair through biological tissue regeneration. Synovial mesenchymal stem
cells (MSCs) may represent an optimal source of chondrogenic cells for
joint resurfacing protocols However, until now, the deﬁnition of MSCs has
relied merely on the retrospective analysis of in vitro culture-expanded
cell populations. Moreover, MSCs undergo phenotypic rearrangements
during culture expansion becoming heterogeneous with spontaneous
differentiation and senescence. The resulting variability may affect the
outcome of clinical applications. The aim of this study is the identiﬁcation
of marker sets for consistent enrichment/puriﬁcation of MSCs from the
human synovium.
Methods: Synovial cells were isolated enzymatically from human
synovium specimens obtained after informed consent from patients
with osteoarthritis undergoing joint replacement. Flow cytometric
phenotypic analysis on freshly isolated and culture-expanded synovial
cells was performed using multiple combinations of conventional MSC
markers (CD106, CD271, CD73, CD90, CD13, CD81, CD105 and CD39) in
association with CD45, a pan-hematopoietic cell marker not expressed
by MSCs. Sorting was carried out using the FACS DiVA high speed
digital cell sorter. Sorted cell populations were assessed for clonoge-
nicity, kinetics of growth and chondro-osteogenic differentiation in
vitro.
Results: Analysis of the phenotype of culture-expanded synovial cells
showed that they were largely negative for CD45, as expected, and
positive in varying proportions for the MSC markers tested. After removal
from their natural environment, MSCs underwent phenotypic rear-
rangements during in vitro culture, losing the expression of LNGFR and
CD106 and acquiring other markers such as CD166 and CD146. After
culture expansion, two functionally distinct cell subsets revealed peculiar
abilities after sorting. The CD73posCD39neg fraction was signiﬁcantly
more clonogenic and proliferative but less chondrogenic and osteogenic
than the CD73posCD39pos fraction. However, no signiﬁcant differences in
terms of kinetics of growth, clonogenicity and chondro-osteogenic
potential were observed when the CD73posCD39neg and the
CD73posCD39pos cell subsets were puriﬁed directly from freshly isolated
synovial cell populations.
Conclusions: Our ﬁndings indicate that, in keeping with the literature,
culture conditions can profoundly inﬂuence MSC phenotype. MSCsundergo phenotypic and functional change due to the removal from their
niches and the use of chemical and physical growth conditions. Notably,
we provide evidence of existence of MSC subsets within culture-expanded
synovial cell populations, which display distinct chondro-osteogenic
potency. The puriﬁcation of MSCs with predictable biological activity will
allow the development of consistent MSC-based joint resurfacing proto-
cols for osteoarthritis.539
TYPE I COLLAGEN AND HEPARAN SULFATE SCAFFOLDS SUPPORT
HUMAN CHONDROGENESIS FOR CARTILAGE TISSUE ENGINEERING
S. Díaz-Prado 1,2, E. Muiños-López 1, T. Hermida-Gómez 1, I. Fuentes-
Boquete 1,2, P. Esbrit 3, J. Buján 4, F.J. De Toro 1,2, F.J. Blanco 1. 1 INIBIC-
CHUAC, A Coruña, Spain; 2 INIBIC-Univ. of A Coruña, A Coruña, Spain;
3 Fundación Jiménez Díaz (Capio Group), Madrid, Spain; 4Dept. of Med.
Specialties. Univ. of Alcalá de Henares, Madrid, Spain
Purpose: Evaluate the proliferation and chondrogenic potential of
human bone marrow mesenchymal stem cells (hBM-MSCs) grown on
type I collagen and different concentrations of heparan sulfate (HS)
scaffolds.
Methods: hBM-MSCs and chondrocytes were cultured (150.000 cells/cm2)
on the scaffolds for 16 and 30 days. We performed 12 groups of study
(Table 1). hBM-MSCs were cultured in chondrogenic medium or DMEM
with 20% FBS plus 100 nM PTHrP. Chondrocytes were grown in DMEM
with 10% FBS plus 100 nM PTHrP. Chondrogenic differentiation was
conﬁrmed by histochemical and immunohistochemical analysis. Trans-
mission (TEM) and scanning (SEM) electronic microscopy were performed
to study the cell interior and the morphology.
Results: hBM-MSCs and chondrocytes were able to proliferate on type I
collagen and various concentrations of HS scaffolds, since cells showed
high percentages of positivity for PCNA proliferation marker (Fig. 1A).
Increased cell proliferation has been associated with a high rate of scaffold
degradation. The results indicated that hBM-MSCs proliferated better in
chondrogenic medium than in the usual growth medium (DMEM 20%).
The study groups with hBM-MSCs grown in chondrogenic medium +100
nM PTHrP, regardless the HS concentration, showed high percentage of
cells regarding the scaffold area (more than 80% after 16 days in culture
and more than 90% after 30 days in culture). Moreover, they also showed
high percentages of positivity for safranin O and type II collagen (Figure 1B
and C). Hematoxylin-eosin (H-E) (Fig. 1D) and Masson’s trichrome stain-
ings showed that cells formed aggregates and produced extracellular
matrix. By scanning electron microscopy (SEM) we studied the cell
morphology in culture over the biomaterials (Fig. 1E). Transmission elec-
tron microscopy (TEM) showed that cells had many ribosomes, large
number of lipid vacuoles and the accumulation of glycogen, characteristic
of the cells with a high activity (Fig. 1F).
Conclusions: Our data demonstrated that type I collagen and heparan
sulfate scaffolds were optimal for hBM-MSCs and chondrocyte growth and
that hBM-MSCs cultured over these scaffolds on chondrogenic medium
were able to differentiate to chondrocyte-like cells.
